Projects per year
-
Phase 3_NavitoclaxRuxolitinib_Myelofibrosis_Abbvie M20-178 Transform-2
Shah, S., Darcourt, J., Pingali, S. R. & Rice, L.
6/7/21 → …
Project: Clinical Trial
-
Phase II_PevonedistatVenetoclaxAzacitidine_AML_Pevonedistat-2002Takeda A Randomized, Open-label, Controlled, Phase 2 Study of Pevonedistat, Venetoclax, and Azacitidine Versus Venetoclax Plus Azacitidine in Adults With Newly Diagnosed Acute Myeloid Leukemia Who Are Unfit for Intensive Chemotherapy
Shah, S., Darcourt, J., Ganguly, S., Petkova, J., Pingali, S. R. & Rice, L.
4/30/21 → …
Project: Clinical Trial
-
A Phase 2 Open-label Study of Brentuximab Vedotin in Front-line Therapy of Hodgkin Lymphoma (HL) an dCD30-expressing Peripheral T-cell Lymphoma (PTCL) in Older Patients or Patients With Significant Comorbidities Ineligible for Standard Chemotherapy
Pingali, S. R., Darcourt, J., Ganguly, S., Petkova, J., Rice, L. & Shah, S.
7/8/20 → …
Project: Clinical Trial
-
A Phase 2, Multicenter, Single-arm Study of Retreatment With Brentuximab Vedotin in Subjects With Relapsed or Refractory Classic Hodgkin Lymphoma (cHL) or CD30-expressing Peripheral T Cell Lymphoma (PTCL)
Pingali, S. R., Abdelrahim, M., Bernicker, E. H., Chang, J. C., Darcourt, J., Ganguly, S., Heyne, K., Niravath, P. A., Petkova, J., Rice, L., Shah, S. & Singh, M.
7/8/20 → …
Project: Clinical Trial
-
Phase III_Parsaclisib and Ruxolitinib_Myelofibrosis_INCB 50465-313 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Combination of PI3K Inhibitor Parsaclisib and Ruxolitinib in Participants With Myelofibrosis
Shah, S., Darcourt, J., Ganguly, S., Petkova, J., Pingali, S. R. & Rice, L.
Project: Clinical Trial